The MedTech Europe blog

Archives for

Centralised procurement of medical technologies is an increasingly prevalent phenomenon in the EU, and one that all stakeholders in this field, whether for or against it, have strong opinions on. Purchasers have embraced centralised procurement as a means to drive down costs. Suppliers fiercely oppose it as it would limit market opportunities and slow down… » read more

Posted by MedTech Europe

Having read Commissioner Dalli’s analysis of the PIP case and the Commission’s plans for strengthening the medical devices directives, it becomes clear that the medical technology industry and the Commissioner share the same view on safety and innovation. “Trust and confidence of consumers in our systems is the basic premise on which all else rest”,… » read more

Posted by MedTech Europe